🌐 ocrelizumab
Ocrelizumab is a pharmaceutical company specializing in the development and global distribution of immunotherapy treatments for multiple sclerosis and other autoimmune diseases.
2
Signals
2
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Photoswitch drug shows early signs of restoring light sensitivity in severely damaged retinas in first human trial | expired | Health | involved | 88% | |
| Study reveals how people use AI for mental health support—and their concerns about it | expired | Health | involved | 96% |